This Class D IVDR Certified product detects clinically relevant seasonal respiratory viruses Influenza A, Influenza B, Respiratory Synctial Virus (A&B) and SARS-CoV-2 virus in a single-well multiplex qPCR test
Infections caused by Flu A, Flu B, RSV (A & B), and SARS-CoV-2 can all present with similar clinical symptoms. Adopt PlexPCR® Flu/RSV/SARS-CoV-2 to triage and diagnose these important seasonal respiratory viruses upfront.
With peaks in seasonal respiratory test numbers, sample workload for laboratories can push testing capacity. Prioritising detection of common respiratory viruses with a uniform testing approach can improve efficiency and productivity.
Take advantage of our flexible workflow to achieve scalable throughput, easily adapting to seasonal test surges.
The COVID-19 pandemic and recent respiratory testing seasons have impacted laboratories with dramatic fluctuations in testing demands and staffing. Some laboratories are left with underused equipment and a drive to replace lost revenue, highlighting the need for affordable and efficient solutions.
PlexPCR® Flu/RSV/SARS-CoV-2 can help your laboratory work effectively and efficiently.
Demonstrated clinical performance – for more detail please see the PlexPCR® Flu/RSV/SARS-CoV-2 Instructions for Use.
Performance of PlexPCR® Flu/RSV/SARS-CoV-2 | |||||
---|---|---|---|---|---|
Flu A | Flu B | RSV | SARS-CoV-2 | ||
Sensitivity | 100.0% | 94.60% | 97.20% | 99.00% | |
Specificity | 99.00% | 99.30% | 98.90% | 95.80% |
PlexPCR® Flu/RSV/SARS-CoV-2 is a single-well, multiplex qPCR assay, for the detection of Influenza A (Flu A), Influenza B (Flu B), Respiratory Syncytial Viruses A and B (RSV A and B) and SARS-CoV-2, plus an endogenous control.
Influenza A (Flu A), Influenza B (Flu B), Respiratory Syncytial Viruses (RSV) A and B, SARS-CoV-2, plus an endogenous Control
Swabs: nasopharyngeal swabs only
Products are shipped on dry ice or ice gel packs.
Expiry dates are stated on the labels. It is recommended that freeze/thaw cycles be limited to less than 12. Store protected from light at – 25°C to – 15°C.
For in vitro diagnostic use. Not for sale in the USA.
IVDR Certified
Please contact your local representative if you can’t find what you are looking for.
For information contact [email protected]
For information contact [email protected]
For information contact [email protected]
For information contact [email protected]
Please contact SpeeDx for information about offering SpeeDx diagnostics in your clinic or for a list of current pathology clinics where SpeeDx testing is available.
Product | Compatible | Size | Catalogue |
---|---|---|---|
PlexPCR® Flu/RSV/SARS-CoV-2 | QuantStudio 5 | 192 reactions† | 1703192 |
Product | Compatible | Size | Catalogue |
Positive Control Flu/RSV/SARS | QuantStudio 5 | 2 x 1 swabs |
95006 |
PlexPrep® Liquid Handler | Enquire | 1 unit | 6600200-01 |
†Additional volumes provided for use with liquid handling systems
PlexPCR® Flu/RSV/SARS-CoV-2 is only available for sale in the E.U.
1 Timothy M Uyeki, David S Hui, Maria Zambon, David E Wentworth, Arnold S Monto (August 2022) Influenza, The Lancet,Seminar Volume 400, Issue 10353, P693-706, August 27, 2022 https://doi.org/10.1016/S0140-6736(22)00982-5
2 Borchers AT, Chang C, Gershwin ME, Gershwin LJ (2013) Respiratory syncytial virus—a comprehensive review. Clin Rev Allergy Immunol 45: 331–379. 10.1007/s12016-013-8368-9
3 Jain H, Schweitzer JW, Justice NA. Respiratory Syncytial Virus Infection. [Updated 2023 Jun 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan https://www.ncbi.nlm.nih.gov/books/NBK459215/
4 https://www.who.int/activities/tracking-SARS-CoV-2-variants